30 June 2025 Appendix 4C Revised

• Corrected items 8.1 to 8.4 in Appendix 4C
• Reported positive net cash from operating activities of $1.554 million
• Cash and cash equivalents at quarter end of $7.668 million

Bioxyne Ltd has released a revised version of its Appendix 4C for the quarter ended 30 June 2025. The company has amended items 8.1 to 8.4 in the report. Specifically, the net cash from operating activities (item 1.9) was $1.554 million, cash and cash equivalents at quarter end (item 4.6) were $7.668 million, and the company had no unused finance facilities available at quarter end (item 7.5). The previous version of the Appendix 4C filed on 24 July 2025 had incorrectly indicated 'N/A' at item 8.1 only. The revised Appendix 4C has been authorised for release by the Company Secretary.